-
Loading metrics
A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis
- Celine Dumont,
- Ulf Sivars,
- Theresa Andreasson,
- Lina Odqvist,
- Johan Mattsson,
- Amy DeMicco,
-
Katerina Pardali,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Writing – original draft
Affiliation Research & Early Development, Respiratory, Inflammation & Autoimmune, R&D BioPharmaceuticals, AstraZeneca, Gothenburg, Sweden
⨯ -
Gustav Johansson,
Roles Data curation, Formal analysis, Investigation, Writing – review & editing
Affiliation Research & Early Development, Respiratory, Inflammation & Autoimmune, R&D BioPharmaceuticals, AstraZeneca, Gothenburg, Sweden
⨯ - Linda Yrlid,
- Rhona J. Cox,
- Frank Seeliger,
- Marie Larsson,
- Ulf Gehrmann ,
-
Andrew M. Davis ,
Roles Data curation, Project administration, Supervision, Writing – original draft
* E-mail: andy.davis@astrazeneca.com (AD); ulf.gehrmann@astrazeneca.com (UG)
Affiliation Research & Early Development, Respiratory, Inflammation & Autoimmune, R&D BioPharmaceuticals, AstraZeneca, Gothenburg, Sweden
⨯ - Outi Vaarala
http://orcid.org/0000-0002-4360-730X
A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis
- Celine Dumont,
- Ulf Sivars,
- Theresa Andreasson,
- Lina Odqvist,
- Johan Mattsson,
- Amy DeMicco,
- Katerina Pardali,
- Gustav Johansson,
- Linda Yrlid,
- Rhona J. Cox
- Published: September 1, 2020
- https://doi.org/10.1371/journal.pone.0222548